Chengdu Illumax Biotechnology Co., Ltd.
Illumax is established in August 2018 and is dedicated to the research, production, and sales of single-test fully automated Clia POCT system, single-test fully automated multiplex immunoassay system, and single-use in vitro diagnostic reagents. Source (opens in a new tab)
- Headquarters
- CN
- Provider types
- CDMO